Stock Events

Stock Events

Inhibikase Therapeutics (IKT) null Earnings

17MayConfirmed

Q2 2020

Dec 20

Mar 21

May 21

-0.26

-0.17

-0.09

0

Details

Expected EPS

N/A

Actual EPS

-0.26

Surprise EPS

-0.26

Surprise Percent

+∞%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.26 per share for .

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.